Latest Cancer News

FDA Approves Keytruda® for Lung Cancer (10-13-2015)
The programmed death (PD-1) inhibitor Keytruda® (pembrolizumab) has been granted approval by the US Food and Drug Administration (FDA) for use in lung cancer, becoming the first PD-1 inhibitor and the... Continue Reading

Opdivo® Improves Survival in Kidney Cancer (10-12-2015)
The immunotherapy agent, Opdivo® (nivolumab), improves survival in kidney cancer compared to the standard treatment, Afinitor® (everolimus). These results were recently published in the New England Journal... Continue Reading

Abemaciclib Receives FDA Breakthrough Therapy Designation in Advanced Breast Cancer (10-9-2015)
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to abemaciclib, a cyclin-dependent kinase (CDK) 4 and 6 inhibitor, for patients with refractory hormone-receptor-positive... Continue Reading

More Cancer News


Youngstownthumb Youngstown
835 Southwestern Run
Youngstown, OH 44514
Phone: 330-318-1100
Fax: 330-318-1111
Warrenthumb Warren
1745 Niles Cortland
Road NE, Suite 5
Warren, OH 44484
Phone: 330-856-8600
Fax: 330-856-8686


Free Wi-Fi Now Available at Both Locations!